Reported Reactions

Devices › Device types

FDA product code MBL · class 2 · Orthopedic

Prosthesis, hip, semi-constrained, uncemented, metal/polymer, porous: medical device reports filed with FDA

1,007 reports carry this product code, 1992–2026; 4 brands with a page.

1,007
reports with this product code
0% of all MAUDE reports
38
reports, 12 months to August 2026
55 in the 12 months before
10.2%
classified as malfunction
62.3% across all reports
0.1%
classified as death, as reported
0.9% across all reports

Product code MBL is FDA's classification for "Prosthesis, hip, semi-constrained, uncemented, metal/polymer, porous" (orthopedic panel), a class 2 device. 1,007 medical device reports carry this product code, 0% of the MAUDE database, from October 1992 to August 2026.

38 reports arrived in the 12 months to August 2026, down 31% from 55 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (89.4%), malfunction (10.2%) and death (0.1%). 4 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
BIOLOX Delta32550%1.9%
Unkn Orthopaedic Reconstruction Dev2170.4%5%
Accolade141.5%36.3%
Femoral Head1110%2.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Limacorporate20.2%
Howmedica Osteonics10.1%

Reports by month, five years

01224Sep 2021: 6Oct 2021: 5Nov 2021: 9Dec 2021: 72022Jan 2022: 1Feb 2022: 5Mar 2022: 1Apr 2022: 2May 2022: 10Jun 2022: 23Jul 2022: 3Aug 2022: 4Sep 2022: 2Oct 2022: 5Nov 2022: 13Dec 2022: 212023Jan 2023: 24Feb 2023: 14Mar 2023: 8Apr 2023: 1May 2023: 8Jun 2023: 2Jul 2023: 4Aug 2023: 4Sep 2023: 2Oct 2023: 3Nov 2023: 5Dec 2023: 32024Jan 2024: 3Feb 2024: 1Mar 2024: 1Apr 2024: 2May 2024: 2Jun 2024: 13Jul 2024: 4Aug 2024: 2Sep 2024: 16Oct 2024: 4Nov 2024: 4Dec 2024: 22025Jan 2025: 4Feb 2025: 1Mar 2025: 3Apr 2025: 1May 2025: 8Jun 2025: 4Jul 2025: 5Aug 2025: 3Sep 2025: 1Oct 2025: 3Nov 2025: 6Dec 2025: 42026Jan 2026: 1Feb 2026: 1Mar 2026: 0Apr 2026: 4May 2026: 5Jun 2026: 3Jul 2026: 7Aug 2026: 3

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.1%1
Injury89.4%900
Malfunction10.2%103
Other0.1%1
Not given0.2%2

Who filed

Manufacturer report98.7%994
Voluntary report0.7%7
User facility report0%0
Distributor report0.2%2
Not given0.4%4

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Insufficient device problem information19119%
Device dislodged or dislocated12712.6%
Connection problema connection problem373.7%
Loose or intermittent connection353.5%
Biocompatibility252.5%
Fitting problem202%
Unintended movement202%
Breakthe device broke171.7%
Unstable171.7%
Fracturea broken bone161.6%
Loosening of implant not related to bone-ingrowth141.4%
Device slipped121.2%
Loss of osseointegration111.1%
Malposition of device101%
Migrationthe device moved from where it was placed101%
Incomplete or inadequate connection90.9%
Failure to align80.8%
Material erosion80.8%
Migration or expulsion of device80.8%
Device operates differently than expectedthe device behaved unexpectedly70.7%

Questions about prosthesis, hip, semi-constrained, uncemented, metal/polymer, porous reports

What is product code MBL?

FDA's classification code for "Prosthesis, hip, semi-constrained, uncemented, metal/polymer, porous", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.

How many reports carry this code?

1,007 reports through August 2026, 38 of them in the latest 12 months.

Which brands appear most often?

BIOLOX Delta (3), Unkn Orthopaedic Reconstruction Dev (2), Accolade (1) and Femoral Head (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.